ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 29

$529K Total Retail Price of All Prescriptions

Rank: 15 out of 29

421 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 9,515 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
NAMENDA 834 776 1 12
POTASSIUM CHLORIDE 502 451 2 6
LISINOPRIL 482 420 3 2
SIMVASTATIN 460 413 4 4
LEVOTHYROXINE SODIUM 437 410 5 1
FUROSEMIDE 414 383 6 3
GABAPENTIN 408 330 7 10
CITALOPRAM HBR 388 338 8 11
AMLODIPINE BESYLATE 381 349 9 5
MIRTAZAPINE 310 301 10 13
DONEPEZIL HCL 277 269 11 9
METFORMIN HCL 248 169 12 19
OMEPRAZOLE 232 217 13 8
DIVALPROEX SODIUM 196 164 14 45
ATENOLOL 176 105 15 23
HYDROCODONE-ACETAMINOPHEN 171 138 S3 16 7
METOPROLOL TARTRATE 168 160 17 15
HYDROCHLOROTHIAZIDE 159 131 18 20
TRAZODONE HCL 155 145 19 22
QUETIAPINE FUMARATE 154 129 20 32
EXELON 120 107 21 38
PRAVASTATIN SODIUM 108 82 22 18
RISPERIDONE 103 83 23 49
LANTUS 98 98 24 39
METOPROLOL SUCCINATE 87 87 25 16
ALENDRONATE SODIUM 81 71 26 26
BACLOFEN 78 0 27 80
WARFARIN SODIUM 76 68 28 14
ALLOPURINOL 75 75 29 40
ISOSORBIDE MONONITRATE ER 71 71 30 44
TRIAMTERENE-HCTZ 65 65 31 48
CLOPIDOGREL 62 57 32 33
ROPINIROLE HCL 59 59 33 94
LAMOTRIGINE 59 35 33 191
DIGOXIN 58 58 35 34
SERTRALINE HCL 57 54 36 17
FLUTICASONE PROPIONATE 57 51 36 43
LOSARTAN POTASSIUM 56 43 38 28
KLOR-CON M20 55 51 39 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 43 39 114
TAMSULOSIN HCL 55 54 39 31
OLANZAPINE 54 50 42 82
SEROQUEL 53 47 43 71
CYMBALTA 52 35 44 29
FLUOXETINE HCL 52 32 44 106
DIOVAN 51 42 46 35
POLYETHYLENE GLYCOL 3350 51 37 46 46
ESCITALOPRAM OXALATE 50 46 48 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.